Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,244) Arrow Down
Filter Results: (1,244) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,244)
    • People  (5)
    • News  (171)
    • Research  (928)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)

Show Results For

  • All HBS Web  (1,244)
    • People  (5)
    • News  (171)
    • Research  (928)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)
← Page 57 of 1,244 Results →
  • 13 Jun 2017
  • First Look

First Look at New Research and Ideas, June 13

Efforts Pay Off? Dynamic Panel Data Methods Revisited By: Chung, Doug J., Byungyeon Kim, and Byoung Park Abstract—We estimate a sales response model to evaluate the short- and long-term value of pharmaceutical sales representatives'... View Details
Keywords: Sean Silverthorne
  • 15 Dec 2014
  • Research & Ideas

Deconstructing the Price Tag

expenses incurred. For example, R&D expenditures in the pharmaceutical industry involve more than just the cost of producing one particular drug. Many drugs may have to fail before one succeeds, and that one hit drug ends up... View Details
Keywords: by Dina Gerdeman; Retail
  • 24 Sep 2007
  • Research & Ideas

The FDA: What Will the Next 100 Years Bring?

food, medicine, or cosmetics you use. Consumers would end up restricting what they buy to a few trusted brands. In effect, the FDA has made competition possible in consumer products and even in pharmaceuticals (particularly through the... View Details
Keywords: by Sean Silverthorne; Biotechnology; Consumer Products; Food & Beverage; Health
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
  • 30 Aug 2016
  • First Look

August 30, 2016

our propositions using empirical data from a large pharmaceutical firm encompassing 407 architectural components and 1,157 dependencies between them. We show that different components occupy different positions in the IT architecture and... View Details
Keywords: Carmen Nobel
  • 17 Sep 2001
  • Research & Ideas

Why E-commerce Didn’t Die With the Fall of Webvan

induced about 12 percent of the pharmaceutical market to buy that way. Once that was done, it was comparatively straightforward to use the same inducements to persuade people who had Web access to do that over the Internet, saving the... View Details
Keywords: by Martha Lagace; Consumer Products; Retail
  • 19 Dec 2005
  • Research & Ideas

The Regional Slice of Your Global Strategy

equipment, and pharmaceuticals have invested significantly in modern mapping technology, using such innovations as enhanced clustering techniques, better measures for analyzing networks, and expanded data on bilateral, multilateral, and... View Details
Keywords: by Pankaj Ghemawat
  • 28 Aug 2017
  • Research & Ideas

Should Industry Competitors Cooperate More to Solve World Problems?

Source: Cecilie_Arcurs George Serafeim has a startling suggestion to fix the world’s biggest environmental, social, and governance (ESG) problems such as water pollution, deforestation, and wealth inequality: encourage companies within industries to do less competing... View Details
Keywords: by Sean Silverthorne; Financial Services; Manufacturing; Agriculture & Agribusiness; Mining
  • 28 May 2008
  • First Look

First Look: May 28, 2008

goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details
Keywords: Martha Lagace
  • 07 Apr 2003
  • Research & Ideas

XTV: Xerox’s Attempted Recovery From “Fumbling the Future”

with researchers at PARC. Much of that time was occupied with interviewing prospective customers who had significant problems with document management. For example, a pharmaceutical company that was applying for FDA approval had to manage... View Details
Keywords: by Henry Chesbrough
  • 01 Sep 2014
  • News

All For One

industries as diverse as automobiles and pharmaceuticals and began to interview and observe them to see how they created environments ripe for innovation. “We didn’t want to just espouse platitudes,” Hill says. “We wanted to tell full... View Details
Keywords: Michael Blanding; faculty; research; Market Research, Photo, Translation, Veterinary and Other Services; Professional Services
  • January 2015 (Revised July 2019)
  • Case

CVS Health: Promoting Drug Adherence

By: Leslie John, John Quelch and Robert Huckman
Email mking@hbs.edu for a courtesy copy.

The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
  • February 1985 (Revised July 1993)
  • Case

Puritan Drug Co.

David Thomas takes his first sales management assignment and is faced with a sales rep revolt because of a possible territory reorganization. In addition, his sales division is performing well below the national average. Rewritten version of a case by R.Z. Sorenson. View Details
Keywords: Salesforce Management; Conflict and Resolution; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Moriarty, Rowland T., Jr. "Puritan Drug Co." Harvard Business School Case 585-158, February 1985. (Revised July 1993.)
  • December 2021
  • Case

Zoetis

By: David E. Bell, Damien McLoughlin and Natalie Kindred
Keywords: Strategy; Food; Change Management; Leadership; Diversity; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Bell, David E., Damien McLoughlin, and Natalie Kindred. "Zoetis." Harvard Business School Case 522-041, December 2021.
  • 2022
  • Book

Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]

By: Sabine Pitteloud
En décembre 2020, les Suisses votaient sur l’initiative populaire « pour des multinationales responsables ». Cet épisode récent a rappelé que la régulation de l’activité des sociétés multinationales fait l’objet de luttes politiques, auxquelles participent les... View Details
Keywords: Multinational Enterprise; Multinational Companies; Multinational Corporations; Lobbying; Business & Government Relations; Labor Relations; Relocation; Offshoring And Outsourcing; Corporate Regulation; Transnational Regulation; Multinational Firms and Management; Business and Government Relations; Governing Rules, Regulations, and Reforms; International Relations; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
Citation
Find at Harvard
Purchase
Related
Pitteloud, Sabine. Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]. Genève, Suisse: Librairie Droz, 2022, French ed.
  • 30 Jun 2003
  • Research & Ideas

Computer Security is For Managers, Too

each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on... View Details
Keywords: by Robert D. Austin & Christopher A.R. Darby
  • 02 Apr 2013
  • First Look

First Look: April 2

care needs to go "beyond the pill" and systematically integrate combinations of treatments. We discuss the implications of this approach for organizational and business models in the pharmaceutical industry. 2006 World Politics... View Details
Keywords: Sean Silverthorne
  • 02 Aug 2004
  • Research & Ideas

Health Care Research and Prospects

series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
Keywords: by Wendy Guild Swearingen; Health
  • Research Summary

Overview

Dr. Crawford conducts research on innovation in the energy industry, with a special focus on emerging business models. She is developing several cases for the EC course, "21st Century Energy," that specifically examine innovations at the interface of IT and Energy — ... View Details
Keywords: Electricity; Prosumer; Smart Grid; Blockchain; Microgrid; Electric Vehicles; Batteries; Energy Storage; Ride-sharing; Smart Cities; Smart Buildings; Smart Meters; Demand Response; "GMOs,"; Corporate Accountability; Responsibilities To Society; Environmental And Social Sustainability; Leadership & Corporate Accountability; Competitive Strategy; Innovation Strategy; Disruptive Innovation; Research and Development; Leadership; Environmental Sustainability; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Asia; United States
  • January 2007 (Revised January 2007)
  • Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
  • ←
  • 57
  • 58
  • …
  • 62
  • 63
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.